Kinfo
Better Therapeutics Inc. logo

Better Therapeutics Inc.

BTTXNASDAQHealthcare·US · USD
$0.00
+0.00 (+0.00%)
Prices as of August 7, 2026 · market closed

Price

Key statistics

Valuation
Market cap5.45K USD
Enterprise value7.71M USD
Trailing P/E-0.00
Forward P/E-0.00
PEG ratio0.00
Price / sales0.00
Price / book-0.00
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-95.05%
Return on equity4422.69%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-29.18M USD
Net income-31.57M USD
Diluted EPS-$1.10
Rev. growth (YoY)0.00%
Balance sheet
Total cash6.60M USD
Total debt14.31M USD
Debt / equity-1.44
Current ratio0.57
Book value / share-$0.25
Cash flow (TTM)
Operating cash flow-26.08M USD
Levered free cash flow-15.56M USD
Shares & price
Shares outstanding40.58M
Float30.54M
Held by institutions0.02%
Beta-37.75
50-day MA$0.00
200-day MA$0.00
52-week high$0.00
52-week low$0.00
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-241.551.68+8.39%2025-11-14-1.72-2.28−32.56%2025-10-292.622.04−22.14%2023-11-09-0.19-0.15+21.05%2023-08-09-0.31-0.24+22.58%
About Better Therapeutics Inc.

Better Therapeutics Inc. is a digital therapeutics company focused on developing prescription digital therapies to treat cardiometabolic diseases. The company integrates cognitive behavioral therapy (CBT) with digital platforms, aiming to provide healthcare solutions that can be prescribed by physicians. A key aspect of its offerings is the utilization of software-based treatment methodologies that are designed to modify behavior and assist in managing conditions such as diabetes, hypertension, and chronic kidney disease. Better Therapeutics operates at the intersection of technology and healthcare, contributing to the growing field of digital health solutions that offer personalized treatment plans without the need for traditional pharmaceuticals. Founded in 2015 and headquartered in San Francisco, California, Better Therapeutics plays a significant role in advancing healthcare innovation by addressing unmet medical needs through digital intervention. Its efforts reflect a shift towards preventive care and the application of behavioral sciences in clinical practice, demonstrating the increasing importance of technology in managing chronic health conditions.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Frank L. Karbe
Employees
54
Headquarters
San Francisco, CA, United States

Frequently asked questions about Better Therapeutics Inc.